— Know what they know.
Not Investment Advice

ONCO NASDAQ

Onconetix, Inc.
1W: -30.1% 1M: +6.8% 3M: -34.5% YTD: -55.3% 1Y: -75.7% 3Y: -100.0%
$0.73
-0.01 (-1.40%)
 
Weekly Expected Move ±33.0%
$0 $0 $1 $1 $1
NASDAQ · Healthcare · Biotechnology · Tech Score Neutral · Power 47 · $2.6M mcap · 1M float · 158.40% daily turnover · Short 55% of daily vol

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$815K -67.7% ▼
Gross Profit
$633K -40.0% ▼
Operating Income
-$6M +88.8% ▲
Net Income
-$14M +76.1% ▲
EPS (Diluted)
$-4.73 +99.1% ▲
EBITDA
-$6M +89.0% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$0$0$58K$3M$815K
YoY Growth+0.0%+0.0%+0.0%+4217.3%-67.7%
Cost of Revenue$5K$7K$1M$1M$182K
Gross Profit-$5K-$7K-$1M$1M$633K
Gross Margin——-1927.9%41.8%77.6%
R&D Expenses$1M$4M$2M$154K$66K
SG&A Expenses$2M$9M$15M$11M$7M
Operating Expenses$3M$13M$35M$58M$7M
Operating Income-$3M-$13M-$36M-$56M-$6M
Operating Margin——-61634.5%-2238.0%-778.2%
Interest Expense$0$0$672K$1M$751K
Income Before Tax-$3M-$13M-$37M-$60M-$14M
Tax Expense$0$0-$13K-$1M$525
Net Income-$3M-$13M-$37M-$59M-$14M
Net Margin——-63986.5%-2325.2%-1721.0%
EPS (Diluted)$-0.31$-1.09$-87.60$-1823.25$-4.73
EBITDA-$3M-$13M-$37M-$58M-$6M
Shares Outstanding324936095032323003M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms